Compare · head to head
GeneDx vs Symbotic
Symbotic ranks higher overall — 360 rank 63 vs 6.
Symbotic leads on Value (46 vs 35), Growth (76 vs 24), Safety (47 vs 42) and Sentiment (65 vs 59). The two are close on Quality.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | USA |
| Sector | Health Care | Industrial Goods |
| Industry | Health Care Providers & Services | Machinery |
| Size | Medium | Large |
| ISIN | US81663L2007 | US87151X1019 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | — | |
| Ranks | ||
| 360 | 6 | 63 |
| Value | 35 | 46 |
| Quality | 28 | 29 |
| Growth | 24 | 76 |
| Safety | 42 | 47 |
| Sentiment | 59 | 65 |
| Quality details | ||
| Profitability | 26 | 5 |
| Cash Truth | 30 | 53 |
GeneDx vs IntappGeneDx vs Upland SoftwareGeneDx vs SalesforceGeneDx vs Viant TechnologyAdd a third stock →
Full analyses: GeneDx · Symbotic
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100